Clozapine treatment of patients with refractory schizophrenia, concurrent dengue infection and hematological abnormalities: three case reports (2014)
- Authors:
- USP affiliated authors: HALLAK, JAIME EDUARDO CECILIO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; MORAIS, SILVIO LUIZ - FMRP
- Unidade: FMRP
- DOI: 10.1177/2045125312464995
- Subjects: DENGUE; ESQUIZOFRENIA; CÉLULAS SANGUÍNEAS; ANTIPSICÓTICOS (EFEITOS ADVERSOS)
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Therapeutic Advances in Psychopharmacology
- ISSN: 2045-1253
- Volume/Número/Paginação/Ano: v. 4, n. 1, p. 83-88, 2014
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
NUNES, Emerson Acoverde et al. Clozapine treatment of patients with refractory schizophrenia, concurrent dengue infection and hematological abnormalities: three case reports. Therapeutic Advances in Psychopharmacology, v. 4, n. 1, p. 83-88, 2014Tradução . . Disponível em: https://doi.org/10.1177/2045125312464995. Acesso em: 19 abr. 2024. -
APA
Nunes, E. A., Rezende, T. M. N., Morais, S. L., Crippa, J. A. de S., Dursun, S. M., Baker, G. B., & Hallak, J. E. C. (2014). Clozapine treatment of patients with refractory schizophrenia, concurrent dengue infection and hematological abnormalities: three case reports. Therapeutic Advances in Psychopharmacology, 4( 1), 83-88. doi:10.1177/2045125312464995 -
NLM
Nunes EA, Rezende TMN, Morais SL, Crippa JA de S, Dursun SM, Baker GB, Hallak JEC. Clozapine treatment of patients with refractory schizophrenia, concurrent dengue infection and hematological abnormalities: three case reports [Internet]. Therapeutic Advances in Psychopharmacology. 2014 ; 4( 1): 83-88.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1177/2045125312464995 -
Vancouver
Nunes EA, Rezende TMN, Morais SL, Crippa JA de S, Dursun SM, Baker GB, Hallak JEC. Clozapine treatment of patients with refractory schizophrenia, concurrent dengue infection and hematological abnormalities: three case reports [Internet]. Therapeutic Advances in Psychopharmacology. 2014 ; 4( 1): 83-88.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1177/2045125312464995 - Cannabidiol monotherapy for treatment-resistant schizophrenia
- The therapeutic potential of harmine and ayahuasca in depression: evidence from exploratory animal and human studies
- Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine
- Postural balance in patients with social anxiety disorder
- Short-term treatment of Catatonia with amantadine in schizophrenia and schizoaffective disorder. [Carta]
- New treatment options for panic disorder: clinical trials from 2000 to 2010
- Public speaking in social phobia: a pilot study of self-ratings and observers' ratings of social skills
- Arterial spin labeling in patients with schizophrenia: a systematic review
- Electroconvulsive therapy for coexistent schizophrenia and obsessive-compulsive disorder
- Randomized, open naturalistic, acute treatment of panic Disorder with clonazepam or paroxetine [carta]
Informações sobre o DOI: 10.1177/2045125312464995 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
